The Thoracic and cardiovascular surgeon
-
Thorac Cardiovasc Surg · Aug 2020
Meta AnalysisLevosimendan Reduces Mortality and Low Cardiac Output Syndrome in Cardiac Surgery.
There has been conflicting evidence concerning the effect of levosimendan on clinical outcomes in patients undergoing cardiac surgery. Therefore, we performed a systematic review and conducted this meta-analysis to provide evidence for/against the administration of levosimendan in cardiac surgery patients. ⋯ Our meta-analysis suggests beneficial effects for the prophylactic use of levosimendan in patients with severely impaired left ventricular function undergoing cardiac surgery. The administration of levosimendan was associated with a reduced mortality, less LCOS, and restored adequate organ perfusion reflected in less acute kidney injury.
-
Thorac Cardiovasc Surg · Aug 2020
Observational StudyStandardized Weaning from Temporary Extracorporeal Life Support in Cardiovascular Patients.
Separation from extracorporeal life support (ECLS) is often based on individual decisions rather than evaluated standard operating procedures (SOPs). Therefore, we strived to evaluate a SOP, summarizing specific treatment paths for this group of patients. ⋯ The SOP for ECLS weaning showed higher weaning rates compared with a weaning based on individual decisions. Although only parts of the SOP were associated with higher weaning and survival rates, the SOP was experienced as a useful guideline for standardized ECLS management.
-
Thorac Cardiovasc Surg · Aug 2020
Nonintubated Uniportal Thoracoscopic Thymectomy with Laryngeal Mask.
To investigate whether laryngeal mask anesthesia had more favorable postoperative outcomes than double-lumen tube intubation anesthesia in uniportal thoracoscopic thymectomy. ⋯ Compared with intubated approach, nonintubated uniportal thoracoscopic thymectomy with laryngeal mask is feasible for anterior mediastinum lesion, and patients recovered faster with less complications.